Interwest Venture Management Co
- SEC CIK
- 0001697720
- Latest filing
- Oct 20, 2023
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed Apr 15, 2021. Long positions only.
- Positions
- 12
- No 13F data for Q4 2020
- Portfolio value
- $380.2M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PMVPPMV Pharmaceuticals, Inc. | COM | 5,469,911 | $179.9M | 47.3% | – | – | History |
| AIC3.ai, Inc. | Stock | 1,386,774 | $91.4M | 24.0% | – | – | History |
| REALTheRealReal, Inc. | COM | 2,354,080 | $53.3M | 14.0% | – | – | History |
| GKOSGLAUKOS Corp | COM | 346,364 | $29.1M | 7.6% | – | – | History |
| AGTCApplied Genetic Technologies Corp | COM | 1,404,515 | $7.12M | 1.9% | – | – | History |
| EIGREiger BioPharmaceuticals, Inc. | COM | 764,918 | $6.77M | 1.8% | – | – | History |
| STIMNeuronetics, Inc. | COM | 497,158 | $6.15M | 1.6% | – | – | History |
| CDTXCidara Therapeutics, Inc. | COM | 1,356,813 | $3.61M | 0.9% | – | – | History |
| VEROVenus Concept Inc. | COM | 658,657 | $1.55M | 0.4% | – | – | History |
| Obalon Therapeutics Inc67424L209 | COM NEW | 380,224 | $1.07M | 0.3% | – | – | – |
| XENEXenon Pharmaceuticals Inc. | COM | 8,293 | $148.0K | <0.1% | – | – | History |
| DAREDare Bioscience, Inc. | COM | 50,368 | $85.0K | <0.1% | – | – | History |